Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Go back to Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 102.13 +3.91 (3.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.22 | 52 Week High | $118.49 | |||
| Open | $99.79 | 52 Week Low | $55.00 | |||
| Day High | $102.31 | P/E | N/A | |||
| Day Low | $99.79 | EPS | $-0.56 | |||
| Volume | 548,255 | |||||
